financetom
Business
financetom
/
Business
/
Sanofi to Invest at Least $20 Billion in US Through 2030
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sanofi to Invest at Least $20 Billion in US Through 2030
May 26, 2025 7:57 AM

12:45 PM EDT, 05/14/2025 (MT Newswires) -- Sanofi ( SNY ) plans to invest at least $20 billion in the US through 2030.

The investment includes "a significant increase in research and development spending and the allocation of billions of dollars to US manufacturing," the Paris-based company said Wednesday in a statement.

Price: 49.07, Change: -0.89, Percent Change: -1.78

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Redwire Secures European Space Agency Contract for Argonaut Lunar Lander Robotic Arm Prototype
Redwire Secures European Space Agency Contract for Argonaut Lunar Lander Robotic Arm Prototype
May 22, 2024
10:56 AM EDT, 05/22/2024 (MT Newswires) -- Redwire ( RDW ) said Wednesday it has secured a contract from the European Space Agency to develop a robotic arm prototype for the agency's Argonaut Lunar Lander. The system, called the Manipulator for Argonaut Payload Needs and Unloading Support, will support surface logistics, including offloading, positioning and retrieval of cargo as well...
Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity
Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity
May 22, 2024
10:54 AM EDT, 05/22/2024 (MT Newswires) -- Scholar Rock ( SRRK ) said Wednesday it has started the phase 2 proof-of-concept trial to evaluate the safety and effectiveness of apitegromab in preserving lean muscle mass in persons living with obesity and receiving glucagon-like peptide-1, or GLP-1, receptor agonist. The trial's results will guide the development of SRK-439, an investigational selective...
JP Morgan appoints former Goldman Sachs banker to lead German business
JP Morgan appoints former Goldman Sachs banker to lead German business
May 22, 2024
FRANKFURT, May 22 (Reuters) - JP Morgan has appointed former Goldman Sachs banker Alexander Mayer as the new head of its German and Austrian business, the U.S. investment bank said in a memo seen by Reuters on Wednesday. Mayer previously spent 24 years at Goldman Sachs ( GS ), most recently as head of Investment Banking for Germany and Austria....
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
May 22, 2024
NeuroBo Pharmaceuticals Inc shares were down more than 6% at last check Wednesday. The Boston-based company announced preclinical data for its novel “G-Protein-Coupled Receptor 119 (GPR119) agonist,” known as DA-1241. The data from a study on mice suggests that DA-1241 — combined with Novo Nordisk A/S’s semaglutide (Wegovy) — improves liver fibrosis. It also demonstrates additive hepatoprotective effects compared to either treatment alone. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved